Rare clinical case of the diagnosis of idiopathic pulmonary artery hypertension

Grigory A. Ignatenko , Ilya S. Grekov , Marina V. Grushina , Anna V. Dubovyk

I.P. Pavlov Russian Medical Biological Herald ›› 2021, Vol. 29 ›› Issue (2) : 299 -304.

PDF (280KB)
I.P. Pavlov Russian Medical Biological Herald ›› 2021, Vol. 29 ›› Issue (2) : 299 -304. DOI: 10.17816/PAVLOVJ48940
Clinical reports
review-article

Rare clinical case of the diagnosis of idiopathic pulmonary artery hypertension

Author information +
History +
PDF (280KB)

Abstract

In this work, a rather rare (morbidity of about 1–2 cases per 1 million of adult population per year) and interesting clinical case of the diagnosis of idiopathic pulmonary artery hypertension (IPAH) was described. This case was also known as Ayerza disease or Ayerza–Arilago syndrome. At the initial stage, this pathology was characterized by an asymptomatic course that caused certain difficulties in making a correct diagnosis. In general, this disease had a poor prognosis. The main cause of death was decompensated right ventricular failure. The occurrence of complications could be significantly reduced and the life quality of such patients could be improved by the timely diagnosis and correct approach.

Keywords

primary pulmonary artery hypertension / IPAH / Ayerza disease / right ventricle / serotonin / sildenafil

Cite this article

Download citation ▾
Grigory A. Ignatenko, Ilya S. Grekov, Marina V. Grushina, Anna V. Dubovyk. Rare clinical case of the diagnosis of idiopathic pulmonary artery hypertension. I.P. Pavlov Russian Medical Biological Herald, 2021, 29(2): 299-304 DOI:10.17816/PAVLOVJ48940

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Chazova IE, Martynyuk TV, Valieva ZS, et al. Eurasian clinical guidelines on diagnosis and treatment of pulmonary hypertension. Eurasian Heart Journal. 2020;(1):78-122. (In Russ.) doi: 10.38109/2225-1685-2020-1-78-122

[2]

Чазова И.Е., Мартынюк Т.В., Валиева З.С., и др. Евразийские клинические рекомендации по диагностике и лечению легочной гипертензии // Евразийский кардиологический журнал. 2020. № 1. С. 78-122. doi: 10.38109/2225-1685-2020-1-78-122

[3]

Galiè N, Humbert M, Vachiery J-L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Respiratory Journal. 2015;46(4):903-75. doi: 10.1183/13993003.01032-2015

[4]

Galiè N., Humbert M., Vachiery J.-L., et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension // European Respiratory Journal. 2015. Vol. 46, № 4. P. 903-975. doi: 10.1183/13993003.01032-2015

[5]

Kochetov VE. Aerza-Arrilaga syndrome: pathogenesis and pathophysiology. Bulletin of Emergency Medicine. 2016; 9(1):107-11. (In Russ).

[6]

Кочетов В.Е. Синдром Аэрза-Арилаго: патогенез и патофизиология // Вестник экстренной медицины. 2016. Т. 9, № 1. С. 107-111.

[7]

Tsareva NA. Updated classification and diagnosis of pulmonary hypertension. Consilium Medicum. 2017;19(3):66-71. (In Russ).

[8]

Царева Н.А. Современная классификация и диагностика легочной гипертензии // Consilium Medicum. 2017. Т. 19, № 3. С. 66-70.

[9]

Martyniuk TV, Chazova IE. Strategy of medical treatment of pulmonary arterial hypertension in the current international recommendations. Systemic Hypertension. 2016;13(2):46-64. (In Russ).

[10]

Мартынюк Т.В., Чазова И.Е. Стратегия медикаментозного лечения легочной артериальной гипертензии в свете современных зарубежных рекомендаций // Системные гипертензии. 2016. Т. 13, № 2. С. 46-64.

RIGHTS & PERMISSIONS

Ignatenko G.A., Grekov I.S., Grushina M.V., Dubovyk A.V.

AI Summary AI Mindmap
PDF (280KB)

173

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/